Mersana Therapeutics, Inc.
MRSN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$69,192 | -$171,670 | -$204,212 | -$170,060 |
| Dep. & Amort. | $1,628 | $1,517 | $927 | $855 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $16,458 | $21,136 | $21,522 | $18,409 |
| Change in WC | -$30,738 | -$18,763 | $133,099 | $10,085 |
| Other Non-Cash | -$496 | -$1,102 | -$699 | $723 |
| Operating Cash Flow | -$82,340 | -$168,882 | -$49,363 | -$139,988 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$132 | -$2,168 | -$2,197 | -$648 |
| Net Acquisitions | $0 | $0 | $150,519 | $0 |
| Inv. Purchases | -$133,431 | -$155,919 | -$247,519 | $0 |
| Inv. Sales/Matur. | $145,000 | $277,970 | $97,000 | $0 |
| Other Inv. Act. | $0 | $0 | -$150,519 | $0 |
| Investing Cash Flow | $11,437 | $119,883 | -$152,716 | -$648 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$2,230 | -$262 | -$272 | $18,341 |
| Stock Issued | $5,780 | $93,539 | $150,893 | $43,087 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $542 | $1,398 | $2,396 | $2,218 |
| Financing Cash Flow | $4,092 | $94,675 | $153,017 | $63,646 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$66,811 | $45,676 | -$49,062 | -$76,990 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $175,039 | $129,363 | $178,425 | $255,415 |
| End Cash | $108,228 | $175,039 | $129,363 | $178,425 |
| Free Cash Flow | -$82,472 | -$171,050 | -$51,560 | -$140,636 |